350 related articles for article (PubMed ID: 15734951)
21. The role of serum tetranectin, CA 125, and a combined index as tumor markers in women with pelvic tumors.
Høgdall CK; Mogensen O; Tabor A; Mogensen B; Jakobsen AK; Nørgaard-Pedersen B; Larsen SO; Clemmensen I
Gynecol Oncol; 1995 Jan; 56(1):22-8. PubMed ID: 7821842
[TBL] [Abstract][Full Text] [Related]
22. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
[TBL] [Abstract][Full Text] [Related]
23. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
[TBL] [Abstract][Full Text] [Related]
25. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
Fisken J; Leonard RC; Roulston JE
Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study.
Funston G; Hamilton W; Abel G; Crosbie EJ; Rous B; Walter FM
PLoS Med; 2020 Oct; 17(10):e1003295. PubMed ID: 33112854
[TBL] [Abstract][Full Text] [Related]
27. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):828-34. PubMed ID: 3166483
[TBL] [Abstract][Full Text] [Related]
28. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
Liu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125.
Tamakoshi K; Kikkawa F; Hasegawa N; Ishikawa H; Mizuno K; Kawai M; Tomoda Y
Gynecol Obstet Invest; 1995; 39(2):125-9. PubMed ID: 7737582
[TBL] [Abstract][Full Text] [Related]
30. Genetic, biochemical, and multimodal approaches to screening for ovarian cancer.
Jacobs I
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S22-7. PubMed ID: 7835805
[No Abstract] [Full Text] [Related]
31. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
[TBL] [Abstract][Full Text] [Related]
32. Hyperferritinemia in ovarian cancer.
Yuan CC; Ng HT; Yeh SH; Chen SS; Hsu DS; Ho CH
J Reprod Med; 1988 Feb; 33(2):193-5. PubMed ID: 3351817
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
34. [Field trial of the early detection in patients with ovarian cancer].
Kobayashi H; Sumimoto K; Terao T; Kawashima Y; Kouda M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1743-9. PubMed ID: 2480393
[TBL] [Abstract][Full Text] [Related]
35. [Study on the pretherapeutic differential diagnosis of adnexal tumors].
Kunz J; Kunz B
Praxis (Bern 1994); 1995 Nov; 84(46):1342-8. PubMed ID: 7491464
[TBL] [Abstract][Full Text] [Related]
36. The effect of renal function on serum levels of CA 125.
Menzin AW; Kobrin S; Pollak E; Goodman DB; Rubin SC
Gynecol Oncol; 1995 Sep; 58(3):375-7. PubMed ID: 7672704
[TBL] [Abstract][Full Text] [Related]
37. [Is CA125 useful in the management of recurrence of endometrial carcinoma?].
Sato K; Mizuuchi H; Mori Y; Okamura N; Endo T; Ito E; Kudo R
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Sep; 47(9):917-24. PubMed ID: 7594902
[TBL] [Abstract][Full Text] [Related]
38. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
Shan D; Cheng S; Ma Y; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
[TBL] [Abstract][Full Text] [Related]
40. [Induction of manganese superoxide dismutase in ovarian carcinoma].
Ishikawa M; Nakata T; Shimizu T; Taniguchi N
Rinsho Byori; 1992 Apr; 40(4):359-62. PubMed ID: 1593761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
